VANDERBILT UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: http://www.vumc.org

Clinical Trials

Sensory Symptoms in Tourette Syndrome and Obsessive-Compulsive Disorder

Completed

Conditions: Obsessive-Compulsive Disorder
Sensory Disorders
Tourette Syndrome

Interventions: Other: None - observational study

First Posted Date: 2020-04-06

Last Posted Date: 2022-03-15

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 250

Registration Number: NCT04335175

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Impact of Journal Program on Wellbeing of NICU Parents

Not Applicable

Completed

Conditions: Depression
Anxiety

Interventions: Behavioral: Journaling
Behavioral: Anxiety and depression screening

First Posted Date: 2020-04-02

Last Posted Date: 2020-04-02

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 100

Registration Number: NCT04331925

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Tissue Growth Characterization for Cochlear Implant Users

Not Applicable

Conditions: Cochlear Implant

Interventions: Procedure: cochlear implant revision surgery

First Posted Date: 2020-03-24

Last Posted Date: 2024-07-15

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 24

Registration Number: NCT04320251

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction in ICU Survivors, 2nd Study

Recruiting

Conditions: Intensive Care Unit Delirium
Critical Illness

First Posted Date: 2020-03-12

Last Posted Date: 2024-03-05

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 567

Registration Number: NCT04305600

Locations: 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Efficacy and Safety of Dapagliflozin in Acute Heart Failure

Phase 3

Completed

Conditions: Diabetes Mellitus, Type 2
Heart Failure

Interventions: Other: Protocolized Diuretic Therapy
Drug: Dapagliflozin 10 MG

First Posted Date: 2020-03-06

Last Posted Date: 2024-03-15

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 240

Registration Number: NCT04298229

Locations: 🇺🇸
INTEGRIS, Oklahoma City, Oklahoma, United States
🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

and more 3 locations

Bridging the Childhood Epilepsy Treatment Gap in Africa

Not Applicable

Active, not recruiting

Conditions: Epilepsy

Interventions: Other: Task-shifting of follow-up care for pediatric epilepsy
Other: Enhanced usual care for pediatric epilepsy

First Posted Date: 2020-03-02

Last Posted Date: 2024-07-08

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 1800

Registration Number: NCT04290975

Locations: 🇳🇬
Aminu Kano Teaching Hospital, Kano, Nigeria
🇳🇬
Federal Neuro-Psychiatric Hospital, Kaduna, Nigeria
🇳🇬
Ahmadu Bello University Teaching Hospital, Zaria, Nigeria

Platelet PAR-1 Activation in Health and Diabetes

Active, not recruiting

Conditions: Type 2 Diabetes
Healthy

First Posted Date: 2020-02-21

Last Posted Date: 2024-02-13

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 100

Registration Number: NCT04280549

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH

Phase 2

Completed

Conditions: Pulmonary Arterial Hypertension

Interventions: Drug: ESR-specific PET scan

First Posted Date: 2020-02-21

Last Posted Date: 2024-03-01

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 66

Registration Number: NCT04280523

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Pharmacologic Modulation of Hippocampal Activity in Psychosis

Phase 2

Terminated

Conditions: Schizophrenia; Psychosis

Interventions: Drug: Levetiracetam 500 mg

First Posted Date: 2020-02-20

Last Posted Date: 2021-08-05

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 1

Registration Number: NCT04277936

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome

Not Applicable

Completed

Conditions: Bladder Pain Syndrome
Painful Bladder Syndrome
Interstitial Cystitis
Cystitis, Interstitial
Interstitial Cystitis (Chronic) With Hematuria
Chronic Interstitial Cystitis
Interstitial Cystitis (Chronic) Without Hematuria
Cystitis, Chronic Interstitial
Interstitial Cystitis, Chronic
Chronic Prostatitis

Interventions: Behavioral: Psychosocial Treatment
Behavioral: Attention Control

First Posted Date: 2020-02-19

Last Posted Date: 2023-08-08

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 78

Registration Number: NCT04275297

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy